(6aR)-6aβ,7,10,10aα-テトラヒドロ-6,6-ジメチル-9-(ヒドロキシメチル)-3-(1,1-ジメチルヘプチル)-6H-ジベンゾ[b,d]ピラン-1-オール

DEA NFLIS-Drug Category -> Synthetic Cannabinoids

Pharmaceuticals -> Synthetic Cannabinoids or Psychoactive Compounds

Synthetic Cannabinoids

Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade.

Drugs used to prevent NAUSEA or VOMITING.

Drugs that bind to but do not activate excitatory amino acid receptors, thereby blocking the actions of agonists.

Drugs intended to prevent damage to the brain or spinal cord from ischemia, stroke, convulsions, or trauma. Some must be administered before the event, but others may be effective for some time after. They act by a variety of mechanisms, but often directly or indirectly minimize the damage produced by endogenous excitatory amino acids.